How to Discuss GLP-1 Side Effects with Your Doctor

    •By Trimi Medical Team•8 min read

    Many patients downplay their side effects or feel like they should "just push through." But your provider needs accurate information to help you. Untreated side effects lead to medication discontinuation, which means losing the weight loss benefits entirely. Here is how to communicate effectively about what you are experiencing.

    Medical Disclaimer: This article is for informational purposes only. Seek immediate medical attention for severe side effects including persistent vomiting, severe abdominal pain, or signs of pancreatitis.

    Before Your Appointment: Track Your Symptoms

    Your provider can help more effectively when you provide specific information:

    • What: Exact symptoms (nausea, vomiting, constipation, diarrhea, fatigue, headache)
    • When: Time of day, relation to injection day, relation to meals
    • How long: Duration of each episode
    • Severity: Rate 1-10, and whether it affects daily function
    • What helps: What you have tried and whether it worked

    Scripts for Common Situations

    Persistent Nausea

    "I have been experiencing nausea rated about [severity] out of 10, primarily on days [timeframe relative to injection]. It lasts approximately [duration]. I have tried [ginger, smaller meals, timing changes] with [limited/some/no] improvement. It is affecting my ability to [work/eat/exercise]. Can we discuss options like adjusting my dose or adding an anti-nausea medication?"

    Severe Constipation

    "I am having bowel movements only every [number] days since starting/increasing my dose. I have tried increasing fiber to [amount], drinking [amount] of water, and using [any OTC remedies]. It is causing [discomfort/bloating/pain]. What do you recommend?"

    Side Effects Affecting Quality of Life

    "I want to continue this medication because the weight loss benefits are important to me, but the side effects are significantly affecting my daily life. I am [missing work/unable to exercise/not eating enough/unable to socialize]. Can we discuss adjusting the dose, adding supportive medications, or changing the injection timing?"

    What Your Provider Can Do

    • Dose adjustment: Reduce to a better-tolerated dose or slow the titration schedule
    • Supportive medications: Ondansetron for nausea, stool softeners for constipation, acid reducers for reflux
    • Timing changes: Moving injection day or time may help
    • Medication switch: A different GLP-1 medication may have a different side effect profile
    • Lifestyle modifications: Specific dietary changes that reduce symptoms

    Get Responsive Medical Support with Trimi

    Trimi's providers are experienced with GLP-1 side effect management. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

    Frequently Asked Questions

    Should I stop my medication if side effects are severe?

    Contact your provider before stopping. They may recommend a temporary pause, dose reduction, or supportive treatment rather than complete discontinuation. If you are vomiting repeatedly, unable to keep fluids down, or experiencing severe abdominal pain, seek immediate medical attention.

    How do I know if a side effect is serious versus expected?

    Expected side effects (mild nausea, decreased appetite, mild constipation) are manageable and usually improve over time. Serious side effects requiring immediate attention include: severe persistent abdominal pain (possible pancreatitis), persistent vomiting leading to dehydration, vision changes, or allergic reactions.

    Will my provider think I am complaining too much?

    No. Reporting side effects is providing essential clinical information. Your provider needs this data to optimize your treatment. Underreporting side effects is far more problematic than overreporting.

    More on Communication

    View all Communication articles

    Request Dose Increase

    When and how to ask for higher doses.

    Ask About Switching GLP-1

    Exploring medication alternatives.

    Managing GLP-1 Side Effects

    Practical side effect management.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What should patients know about GLP-1 side effects?

    Peer-reviewed / regulatory evidence: In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. (Source: STEP 1, NEJM 2021). Trimi's clinical-review process — coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network — addresses GLP-1 side effects as part of the individualized patient-care plan. Compounded medications are dispensed by 503A community sterile compounding pharmacies (VialsRx, GreenwichRx). This is general information based on the cited sources, not medical advice.

    In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. — STEP 1, NEJM 2021
    In SURMOUNT-1, gastrointestinal adverse events occurred in approximately 81% of tirzepatide 15 mg participants vs 53% of placebo participants over 72 weeks; most resolved with continued therapy and dose adjustment. — SURMOUNT-1, NEJM 2022

    Key Takeaways

    • In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. (Source: STEP 1, NEJM 2021)
    • In SURMOUNT-1, gastrointestinal adverse events occurred in approximately 81% of tirzepatide 15 mg participants vs 53% of placebo participants over 72 weeks; most resolved with continued therapy and dose adjustment. (Source: SURMOUNT-1, NEJM 2022)
    • Most GLP-1 adverse events are gastrointestinal (nausea, vomiting, diarrhea, constipation), mild-to-moderate in severity, and concentrated during dose-escalation weeks. Severe or persistent symptoms should be discussed with the prescribing clinician promptly.
    • GLP-1 receptor agonists require a prescription. Eligibility is determined by a licensed clinician based on BMI, weight-related comorbidities, and screening for contraindications (medullary thyroid carcinoma history, MEN 2, pancreatitis history, severe GI / renal disease, pregnancy, breastfeeding).
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: May 18, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    — Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    — Veronica LarimoreFacebook
    See all community reviews →

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) Prescribing Information — Adverse Reactions section. FDA.Read Study
    2. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information — Adverse Reactions section. FDA.Read Study
    3. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — Safety endpoints. New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183

    Was this article helpful?

    Keep Reading

    Side Effects & Safety

    Noom Med Side Effects 2026: GLP-1 Side Effects & What to Expect

    Comprehensive guide to Noom Med GLP-1 side effects in 2026. Learn about common and rare side effects, how Noom manages them, and how Trimi's $99/mo semaglutide compares.

    11 minRead More
    GLP-1

    Semaglutide 0.25mg Starting Dose

    Guide to semaglutide 0.5mg dose increase. Learn what to expect at the first titration step, typical side effects, weight loss results, and when to advance to 1.0mg.

    10 minRead More
    Medications

    Oral Wegovy 50mg Review 2026: The First Weight Loss Pill That Actually Works

    FDA approved oral Wegovy (semaglutide 50mg tablet) for weight loss in 2026. Review covers clinical trial results (~15% body weight loss), dosing, side effects, cost ($1,000–$1,500/mo), and affordable injectable alternatives.

    14 minRead More
    Side Effects & Safety

    Noom Med Side Effects 2026: GLP-1 Side Effects & What to Expect

    10 minRead More

    Start your GLP-1 journey — from $99/mo

    Get Started